{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:13:00Z","timestamp":1787008380547,"version":"build-2736575974"},"reference-count":121,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The goals of this paper are to (1) provide a brief overview of palliative care, including its purpose and philosophy and how hospice care fits under the larger palliative care umbrella; (2) introduce pain assessment in patients with life-limiting illnesses; and (3) review pain management strategies in palliative care, with a focus on pharmacotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Palliative care is a specialized field of medicine focused on providing patient- and family-centered care for those with life-limiting illnesses at any stage of their disease trajectory. When patients approach their end of life and the focus of care becomes comfort and quality of life, the decision may be made to enter hospice care. Pain management is an essential aspect of palliative and hospice care. An effective pain assessment should help elucidate the cause and type of pain, guiding selection of therapy. Options for treating pain may include nonpharmacological approaches such as physical therapy, interventions such as nerve blocks, and pharmacotherapy. Opioids are the mainstay of pain pharmacotherapy in palliative care, although, depending on patient-specific factors, nonopioids or adjuvant agents may be used instead of or in addition to opioids. Safe and effective pain medication use in serious illness requires careful consideration of which agents should be most effective and well tolerated; clinicians should also be prepared to anticipate and respond to medication adverse effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Because of the outsized importance of safe and effective medication management to treat pain in patients with life-limiting illnesses, pharmacists are particularly well suited to intervene and help guide appropriate therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajhp\/zxaf326","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:10:27Z","timestamp":1764249027000},"page":"470-490","source":"Crossref","is-referenced-by-count":1,"title":["Pain management in hospice and palliative care: A primer for pharmacists"],"prefix":"10.1093","volume":"83","author":[{"given":"Madison N","family":"Irwin","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of Michigan Health , Ann Arbor, MI , and , Ann Arbor, MI ,","place":["USA"]},{"name":"University of Michigan College of Pharmacy , Ann Arbor, MI , and , Ann Arbor, MI ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Hallstrom","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, Henry Ford Hospital , Detroit, MI ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa F","family":"Polat","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, Henry Ford Hospital , Detroit, MI ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Fagan","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, Henry Ford Hospital , Detroit, MI ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Quirk","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, Henry Ford Hospital , Detroit, MI , and , Detroit, MI ,","place":["USA"]},{"name":"Department of Pharmacy, Henry Ford Hospital , Detroit, MI , and , Detroit, MI ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"2026050703121185200_zxaf326-B1","author":"National Institute on Aging"},{"issue":"6","key":"2026050703121185200_zxaf326-B2","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1001\/jamaoncol.2019.0081","article-title":"Association of expanded VA hospice care with aggressive care and cost for veterans with advanced lung cancer","volume":"5","author":"Mor","year":"2019","journal-title":"JAMA Oncol"},{"issue":"1","key":"2026050703121185200_zxaf326-B3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/NJH.0000000000000918","article-title":"Conceptualizing the value of pediatric concurrent hospice care","volume":"25","author":"Sharp","year":"2023","journal-title":"J Hosp Palliat Nurs"},{"issue":"8","key":"2026050703121185200_zxaf326-B4","doi-asserted-by":"publisher","first-page":"e232603","DOI":"10.1001\/jamahealthforum.2023.2603","article-title":"Concurrent care as the next frontier in end-of-life care","volume":"4","author":"Ernecoff","year":"2023","journal-title":"JAMA Health Forum"},{"key":"2026050703121185200_zxaf326-B5","doi-asserted-by":"publisher","first-page":"1210370","DOI":"10.3389\/fpain.2023.1210370","article-title":"Improvement in medical students\u2019 knowledge on chronic pain assessment through integrative learning approaches: a randomized controlled trial","volume":"4","author":"Soenarto","year":"2023","journal-title":"Front Pain Res"},{"issue":"1","key":"2026050703121185200_zxaf326-B6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/01.JAM.0000043422.31640.F7","article-title":"Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale","volume":"4","author":"Warden","year":"2003","journal-title":"J Am Med Dir Assoc"},{"issue":"3","key":"2026050703121185200_zxaf326-B7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1460-9592.2005.01773.x","article-title":"The revised FLACC observational pain tool: improved reliability and validity for pain assessment in children with cognitive impairment","volume":"16","author":"Malviya","year":"2006","journal-title":"Paediatr Anaesth"},{"key":"2026050703121185200_zxaf326-B8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1196\/annals.1414.033","article-title":"Cancer pain and analgesia","volume":"1138","author":"Christo","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"2026050703121185200_zxaf326-B9","doi-asserted-by":"crossref","DOI":"10.56021\/9781421443904","volume-title":"Comprehensive Guide to Supportive and Palliative Care for Patients with Cancer","author":"Abraham","year":"2022","edition":"4th ed"},{"issue":"11","key":"2026050703121185200_zxaf326-B10","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1097\/j.pain.0000000000002324","article-title":"Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system","volume":"162","author":"Kosek","year":"2021","journal-title":"Pain"},{"issue":"2","key":"2026050703121185200_zxaf326-B11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11764-021-01153-0","article-title":"The effects of physical exercise in the palliative care phase for people with advanced cancer: a systematic review with meta-analysis","volume":"17","author":"Toohey","year":"2023","journal-title":"J Cancer Surviv"},{"issue":"19","key":"2026050703121185200_zxaf326-B12","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1002\/cam4.4746","article-title":"Impact of physical exercise in advanced-stage cancer patients: systematic review and meta-analysis","volume":"11","author":"Rodr\u00edguez-Ca\u00f1amero","year":"2022","journal-title":"Cancer Med"},{"issue":"1","key":"2026050703121185200_zxaf326-B13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jpainsymman.2024.07.024","article-title":"Effectiveness of music therapy, aromatherapy, and massage therapy on patients in palliative care with end-of-life needs: a systematic review","volume":"69","author":"Jodie","year":"2025","journal-title":"J Pain Symptom Manage"},{"key":"2026050703121185200_zxaf326-B14","volume-title":"Cancer Pain Relief","author":"World Health Organization","year":"1986"},{"issue":"6","key":"2026050703121185200_zxaf326-B15","first-page":"514","article-title":"Is the WHO analgesic ladder still valid? Twenty-four years of experience","volume":"56","author":"Vargas-Schaffer","year":"2010","journal-title":"Can Fam Physician"},{"issue":"suppl 4","key":"2026050703121185200_zxaf326-B16","doi-asserted-by":"publisher","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","article-title":"Management of cancer pain in adult patients: ESMO clinical practice guidelines","volume":"29","author":"Fallon","year":"2018","journal-title":"Ann Oncol"},{"key":"2026050703121185200_zxaf326-B17","volume-title":"Pain assessment and management","author":"Wong","year":"2016:27-67","edition":"2nd ed"},{"issue":"2 suppl","key":"2026050703121185200_zxaf326-B18","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.36076\/ppj.2008\/11\/S133","article-title":"Opioid pharmacology","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician"},{"issue":"4","key":"2026050703121185200_zxaf326-B19","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1200\/JCO.22.02198","article-title":"Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline","volume":"41","author":"Paice","year":"2023","journal-title":"J Clin Oncol"},{"issue":"9-10","key":"2026050703121185200_zxaf326-B20","doi-asserted-by":"publisher","first-page":"e1879","DOI":"10.1093\/milmed\/usad506","article-title":"A pathophysiological approach for selecting medications to treat nociceptive and neuropathic pain in servicemembers","volume":"189","author":"Nguyen","year":"2024","journal-title":"Mil Med"},{"issue":"2","key":"2026050703121185200_zxaf326-B21","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncol"},{"key":"2026050703121185200_zxaf326-B22"},{"key":"2026050703121185200_zxaf326-B23","volume-title":"Hospice and Palliative Medicine Handbook: A Clinical Guide","author":"Bodtke","year":"2016"},{"key":"2026050703121185200_zxaf326-B24","doi-asserted-by":"crossref","DOI":"10.37573\/9781585284306","volume-title":"Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing","author":"McPherson","year":"2018","edition":"2nd ed"},{"issue":"12","key":"2026050703121185200_zxaf326-B25","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1177\/10600280211003875","article-title":"Pharmacogenomics in pain management: a review of relevant gene-drug associations and clinical considerations","volume":"55","author":"Brandl","year":"2021","journal-title":"Ann Pharmacother"},{"key":"2026050703121185200_zxaf326-B26","volume-title":"Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing","author":"McPherson","year":"2010","edition":"1st ed"},{"issue":"3","key":"2026050703121185200_zxaf326-B27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jpainsymman.2017.07.001","article-title":"The conversion ratio from intravenous hydromorphone to oral opioids in cancer patients","volume":"54","author":"Reddy","year":"2017","journal-title":"J Pain Symptom Manage"},{"issue":"8","key":"2026050703121185200_zxaf326-B28","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s00520-024-08710-0","article-title":"Opioid analgesic dose and route conversion ratio studies: a scoping review to inform an eDelphi guideline","volume":"32","author":"Davis","year":"2024","journal-title":"Support Care Cancer"},{"issue":"10","key":"2026050703121185200_zxaf326-B29","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1089\/jpm.2022.0266","article-title":"Opioid rotation and conversion ratios used by palliative care professionals: an international survey","volume":"25","author":"Reddy","year":"2022","journal-title":"J Palliat Med"},{"issue":"10","key":"2026050703121185200_zxaf326-B30","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s11864-023-01117-9","article-title":"Opioid-induced neurotoxicity in patients with cancer pain","volume":"24","author":"Mercadante","year":"2023","journal-title":"Curr Treat Options Oncol"},{"issue":"10","key":"2026050703121185200_zxaf326-B31","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1089\/jpm.2012.0467","article-title":"Incidence of hydromorphone-induced neuroexcitation in hospice patients","volume":"16","author":"Kullgren","year":"2013","journal-title":"J Palliat Med"},{"issue":"1","key":"2026050703121185200_zxaf326-B32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s002130000500","article-title":"Comparing the subjective, psychomotor, and physiological effects of intravenous hydromorphone and morphine in healthy volunteers","volume":"152","author":"Hill","year":"2000","journal-title":"Psychopharmacology"},{"issue":"2","key":"2026050703121185200_zxaf326-B33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2217\/pmt-2020-0048","article-title":"Relative addictive potential of opioid analgesic agents","volume":"11","author":"Connors","year":"2021","journal-title":"Pain Manag"},{"issue":"4","key":"2026050703121185200_zxaf326-B34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s13181-012-0263-x","article-title":"Likeability and abuse liability of commonly prescribed opioids","volume":"8","author":"Wightman","year":"2012","journal-title":"J Med Toxicol"},{"issue":"7","key":"2026050703121185200_zxaf326-B35","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","article-title":"Opioid metabolism","volume":"84","author":"Smith HS","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"2026050703121185200_zxaf326-B36","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/sj.npp.1301479","article-title":"Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers","volume":"33","author":"Comer","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"5-6","key":"2026050703121185200_zxaf326-B37","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/FBP.0b013e328363d1c4","article-title":"Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts","volume":"24","author":"Comer","year":"2013","journal-title":"Behav Pharmacol"},{"issue":"1","key":"2026050703121185200_zxaf326-B38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00213-007-0937-2","article-title":"Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers","volume":"196","author":"Zacny","year":"2008","journal-title":"Psychopharmacology"},{"issue":"12","key":"2026050703121185200_zxaf326-B39","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11864-021-00910-8","article-title":"Treating chronic pain with buprenorphine\u2014the practical guide","volume":"22","author":"Case","year":"2021","journal-title":"Curr Treat Options Oncol"},{"issue":"6","key":"2026050703121185200_zxaf326-B40","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.suponc.2012.05.002","article-title":"Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain","volume":"10","author":"Davis","year":"2012","journal-title":"J Support Oncol"},{"issue":"5","key":"2026050703121185200_zxaf326-B41","doi-asserted-by":"publisher","first-page":"e638","DOI":"10.1016\/j.jpainsymman.2023.06.022","article-title":"Should buprenorphine be considered a first-line opioid for the treatment of moderate to severe cancer pain?","volume":"66","author":"Chwistek","year":"2023","journal-title":"J Pain Symptom Manage"},{"key":"2026050703121185200_zxaf326-B42","volume-title":"VA\/DoD Clinical Practice Guideline for the Use of Opioids in the Management of Chronic Pain","author":"Department of Defense, Department of Veterans Affairs","year":"2022"},{"issue":"9","key":"2026050703121185200_zxaf326-B43","doi-asserted-by":"publisher","first-page":"e2124152","DOI":"10.1001\/jamanetworkopen.2021.24152","article-title":"Evaluation of buprenorphine rotation in patients receiving long-term opioids for chronic pain: a systematic review","volume":"4","author":"Powell","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026050703121185200_zxaf326-B44","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001535","article-title":"Description of physician champion efforts to expand buprenorphine treatment in primary care and explore a quality implementation measure of success: buprenorphine as a percentage of all opioids prescribed","volume":"23","author":"Salmon","year":"2025","journal-title":"J Addict Med."},{"issue":"1","key":"2026050703121185200_zxaf326-B45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1089\/jpm.2021.0378","article-title":"Buprenorphine microdosing for the pain and palliative care clinician","volume":"25","author":"Quirk","year":"2022","journal-title":"J Palliat Med"},{"issue":"5","key":"2026050703121185200_zxaf326-B46","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1185\/03007995.2012.678938","article-title":"Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain","volume":"28","author":"Wolff","year":"2012","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"2026050703121185200_zxaf326-B47","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/annonc\/mdw097","article-title":"Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV \u2018real life\u2019 trial on the variability of response to opioids","volume":"27","author":"Corli","year":"2016","journal-title":"Ann Oncol"},{"issue":"2","key":"2026050703121185200_zxaf326-B48","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jpainsymman.2006.01.013","article-title":"Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine","volume":"32","author":"Mercadante","year":"2006","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"2026050703121185200_zxaf326-B49","doi-asserted-by":"publisher","first-page":"e027374","DOI":"10.1136\/bmjopen-2018-027374","article-title":"Perioperative Pain and Addiction Interdisciplinary Network (PAIN): protocol of a practice advisory for the perioperative management of buprenorphine using a modified Delphi process","volume":"9","author":"Goel","year":"2019","journal-title":"BMJ Open"},{"issue":"12","key":"2026050703121185200_zxaf326-B50","doi-asserted-by":"publisher","first-page":"e2139968","DOI":"10.1001\/jamanetworkopen.2021.39968","article-title":"Expert panel consensus on management of advanced cancer-related pain in individuals with opioid use disorder","volume":"4","author":"Merlin","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"5","key":"2026050703121185200_zxaf326-B51","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/phar.2676","article-title":"Buprenorphine initiation strategies for opioid use disorder and pain management: a systematic review","volume":"42","author":"Spreen","year":"2022","journal-title":"Pharmacotherapy"},{"issue":"3","key":"2026050703121185200_zxaf326-B52","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jpainsymman.2018.12.001","article-title":"Safe and appropriate use of methadone in hospice and palliative care: expert consensus white paper","volume":"57","author":"McPherson","year":"2019","journal-title":"J Pain Symptom Manage"},{"key":"2026050703121185200_zxaf326-B53","author":"Johnson"},{"issue":"3","key":"2026050703121185200_zxaf326-B54","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jpainsymman.2019.04.034","article-title":"Prescribing in chronic severe hepatic impairment","volume":"58","author":"Wilcock","year":"2019","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"2026050703121185200_zxaf326-B55","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/1078155214551589","article-title":"Use of naloxone for reversal of life-threatening opioid toxicity in cancer-related pain","volume":"22","author":"Howlett","year":"2016","journal-title":"J Oncol Pharm Pract"},{"issue":"5","key":"2026050703121185200_zxaf326-B56","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/s1526-5900(03)00556-x","article-title":"Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review","volume":"4","author":"McNicol","year":"2003","journal-title":"J Pain"},{"key":"2026050703121185200_zxaf326-B57","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-39982-5","volume-title":"Pain Management for Clinicians: A Guide to Assessment and Treatment","author":"Noe","year":"2020"},{"issue":"4","key":"2026050703121185200_zxaf326-B58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/15360288.2020.1784355","article-title":"Acetaminophen in patients receiving strong opioids for cancer pain","volume":"34","author":"Quirk","year":"2020","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"5","key":"2026050703121185200_zxaf326-B59","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2165\/00003088-200038050-00001","article-title":"Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach","volume":"38","author":"Davies","year":"2000","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"2026050703121185200_zxaf326-B60","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1592\/phco.28.6.788","article-title":"Management of chronic nonmalignant pain with nonsteroidal antiinflammatory drugs. Joint opinion statement of the Ambulatory Care, Cardiology, and Pain and Palliative Care Practice and Research Networks of the American College of Clinical Pharmacy","volume":"28","author":"Herndon","year":"2008","journal-title":"Pharmacotherapy"},{"issue":"3","key":"2026050703121185200_zxaf326-B61","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/ajg.2009.115","article-title":"Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications","volume":"104","author":"Lanza","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"2026050703121185200_zxaf326-B62","volume-title":"Essential Practices in Hospice and Palliative Medicine: Pain Assessment and Management","author":"Shega","year":"2017","edition":"5th ed"},{"issue":"2","key":"2026050703121185200_zxaf326-B63","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/1049909118797283","article-title":"Differences in adverse effect profiles of corticosteroids in palliative care patients","volume":"36","author":"Jaward","year":"2019","journal-title":"Am J Hosp Palliat Care"},{"issue":"4","key":"2026050703121185200_zxaf326-B64","doi-asserted-by":"publisher","first-page":"CD010756","DOI":"10.1002\/14651858.CD010756.pub2","article-title":"Corticosteroids for the management of cancer-related pain in adults","volume":"2015","author":"Haywood","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"2026050703121185200_zxaf326-B65","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1177\/1049909113504238","article-title":"Pneumocystis pneumonia in patients treated with long-term steroid therapy for symptom palliation: a neglected infection in palliative care","volume":"31","author":"Yamaguchi","year":"2014","journal-title":"Am J Hosp Palliat Care"},{"issue":"6","key":"2026050703121185200_zxaf326-B66","first-page":"427","article-title":"Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain","volume":"39","author":"Witenko","year":"2014","journal-title":"P T"},{"issue":"2","key":"2026050703121185200_zxaf326-B67","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jpainsymman.2004.05.002","article-title":"Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review","volume":"28","author":"Chou","year":"2004","journal-title":"J Pain Symptom Manage"},{"issue":"10090","key":"2026050703121185200_zxaf326-B68","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S0140-6736(17)31744-0","article-title":"Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis","volume":"390","author":"da Costa","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"2026050703121185200_zxaf326-B69","first-page":"365","article-title":"Choosing a skeletal muscle relaxant","volume":"78","author":"See","year":"2008","journal-title":"Am Fam Physician"},{"key":"2026050703121185200_zxaf326-B70","volume-title":"StatPearls","author":"Ghanavatian","year":"2024"},{"key":"2026050703121185200_zxaf326-B71","volume-title":"StatPearls","author":"Ghanavatian","year":"2023"},{"issue":"10","key":"2026050703121185200_zxaf326-B72","doi-asserted-by":"publisher","first-page":"e47071","DOI":"10.7759\/cureus.47071","article-title":"Acetaminophen: a liver killer or thriller","volume":"15","author":"Zacharia","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"2026050703121185200_zxaf326-B73","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jpainsymman.2006.11.013","article-title":"Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: a randomized open trial","volume":"34","author":"Keskinbora","year":"2007","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"2026050703121185200_zxaf326-B74","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2217\/pmt-2018-0052","article-title":"Nonopioid versus opioid agents for chronic neuropathic pain, rheumatoid arthritis pain, cancer pain and low back pain","volume":"9","author":"Noori","year":"2019","journal-title":"Pain Manag"},{"issue":"13","key":"2026050703121185200_zxaf326-B75","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"2026050703121185200_zxaf326-B76","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1093\/pm\/pnz075","article-title":"A comprehensive algorithm for management of neuropathic pain","volume":"20","author":"Bates","year":"2019","journal-title":"Pain Med"},{"issue":"5","key":"2026050703121185200_zxaf326-B77","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S1474-4422(25)00068-7","article-title":"Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysis","volume":"24","author":"Soliman","year":"2025","journal-title":"Lancet Neurol"},{"key":"2026050703121185200_zxaf326-B78","doi-asserted-by":"publisher","DOI":"10.1080\/15360288.2025.2496520","article-title":"Oral ketamine as an analgesic therapy: systematic review of randomised clinical trials","volume":"30","author":"Umbacia","year":"2025","journal-title":"J Pain Palliat Care Pharmacother. Published online April"},{"issue":"7","key":"2026050703121185200_zxaf326-B79","doi-asserted-by":"publisher","first-page":"587","DOI":"10.5863\/1551-6776-27.7.587","article-title":"Applications of dexmedetomidine in palliative and hospice care","volume":"27","author":"Lemus","year":"2022","journal-title":"J Pediatr Pharmacol Ther"},{"key":"2026050703121185200_zxaf326-B80","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3389\/fneur.2019.00954","article-title":"Intra-venous lidocaine to relieve neuropathic pain: a systematic review and meta-analysis","volume":"10","author":"Zhu","year":"2019","journal-title":"Front Neurol"},{"key":"2026050703121185200_zxaf326-B81","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.2147\/JPR.S231948","article-title":"Safety and efficacy of the unique opioid buprenorphine for the treatment of chronic pain","volume":"12","author":"Pergolizzi","year":"2019","journal-title":"J Pain Res"},{"issue":"2","key":"2026050703121185200_zxaf326-B82","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/s0885-3924(01)00393-1","article-title":"Low dose ketamine as an analgesic adjuvant in difficult pain syndromes: a strategy for conversion from parenteral to oral ketamine","volume":"23","author":"Fitzgibbon","year":"2002","journal-title":"J Pain Symptom Manage"},{"issue":"28","key":"2026050703121185200_zxaf326-B83","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J Clin Oncol"},{"issue":"4","key":"2026050703121185200_zxaf326-B84","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/cpt.1004","article-title":"Clinical Pharmacogenetics Implementation Consortium guideline for HLA genotype and use of carbamazepine and oxcarbazepine: 2017 update","volume":"103","author":"Phillips","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"2026050703121185200_zxaf326-B85","first-page":"720","article-title":"Demystifying serotonin syndrome (or serotonin toxicity)","volume":"64","author":"Foong","year":"2018","journal-title":"Can Fam Physician"},{"issue":"8","key":"2026050703121185200_zxaf326-B86","doi-asserted-by":"publisher","first-page":"e085438","DOI":"10.1136\/bmjopen-2024-085438","article-title":"Quantitative analysis of nortriptyline\u2019s analgesic properties: a comparative systematic review and meta-analysis","volume":"14","author":"Hashemzadeh","year":"2024","journal-title":"BMJ Open"},{"key":"2026050703121185200_zxaf326-B87"},{"key":"2026050703121185200_zxaf326-B88"},{"issue":"1","key":"2026050703121185200_zxaf326-B89","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/15360288.2020.1852358","article-title":"Strategies for rotation between gabapentinoids in the inpatient setting","volume":"35","author":"Irwin","year":"2021","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"2026050703121185200_zxaf326-B90","author":"Carbamazepine"},{"issue":"9","key":"2026050703121185200_zxaf326-B91","doi-asserted-by":"publisher","first-page":"CD010111","DOI":"10.1002\/14651858.CD010111","article-title":"Topical capsaicin (low concentration) for chronic neuropathic pain in adults","volume":"2012","author":"Derry","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2026050703121185200_zxaf326-B92","doi-asserted-by":"publisher","first-page":"CD007393","DOI":"10.1002\/14651858.CD007393.pub4","article-title":"Topical capsaicin (high concentration) for chronic neuropathic pain in adults","volume":"1","author":"Derry","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2026050703121185200_zxaf326-B93","doi-asserted-by":"publisher","first-page":"4478","DOI":"10.21037\/apm.2019.09.09","article-title":"The use of ketamine in the management of refractory cancer pain in a palliative care unit","volume":"9","author":"Cheung","year":"2020","journal-title":"Ann Palliat Med"},{"issue":"6","key":"2026050703121185200_zxaf326-B94","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1161\/CIR.0000000000000426","article-title":"Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association","volume":"134","author":"Page","year":"2016","journal-title":"Circulation"},{"issue":"5","key":"2026050703121185200_zxaf326-B95","doi-asserted-by":"publisher","first-page":"e204693","DOI":"10.1001\/jamanetworkopen.2020.4693","article-title":"Association of ketamine with psychiatric symptoms and implications for its therapeutic use and for understanding schizophrenia: a systematic review and meta-analysis","volume":"3","author":"Beck","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2026050703121185200_zxaf326-B96","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3390\/healthcare10030566","article-title":"Ketamine in acute brain injury: current opinion following cerebral circulation and electrical activity","volume":"10","author":"Zanza","year":"2022","journal-title":"Healthcare"},{"issue":"9","key":"2026050703121185200_zxaf326-B97","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1111\/imj.15404","article-title":"Long-term safety and efficacy of sublingual ketamine troches\/lozenges in chronic non-malignant pain management","volume":"52","author":"Maudlin","year":"2022","journal-title":"Intern Med J"},{"issue":"11","key":"2026050703121185200_zxaf326-B98","doi-asserted-by":"publisher","first-page":"e0207427","DOI":"10.1371\/journal.pone.0207427","article-title":"The pharmacokinetics of dexmedetomidine in patients with obstructive jaundice: a clinical trial","volume":"13","author":"Song","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"2026050703121185200_zxaf326-B99","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1213\/ANE.0000000000001125","article-title":"Risk factors for dexmedetomidine-associated hemodynamic instability in noncardiac intensive care unit patients","volume":"122","author":"Ice","year":"2016","journal-title":"Anesth Analg"},{"issue":"2","key":"2026050703121185200_zxaf326-B100","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ams2.265","article-title":"Local anesthetic toxicity: acute and chronic management","volume":"4","author":"Sekimoto","year":"2017","journal-title":"Acute Med Surg"},{"issue":"5","key":"2026050703121185200_zxaf326-B101","doi-asserted-by":"crossref","first-page":"E573","DOI":"10.36076\/ppj.2018.5.E573","article-title":"Mexiletine usage in a chronic pain clinic: indications, tolerability, and side effects","volume":"21","author":"Romman","year":"2018","journal-title":"Pain Physician"},{"issue":"5","key":"2026050703121185200_zxaf326-B102","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.bja.2022.12.013","article-title":"Towards precision pain medicine for pain after cancer: the Cancer Pain Phenotyping Network multidisciplinary international guidelines for pain phenotyping using nociplastic pain criteria","volume":"130","author":"Nijs","year":"2023","journal-title":"Br J Anaesth"},{"issue":"10","key":"2026050703121185200_zxaf326-B103","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1002\/acr.25104","article-title":"Identifying and managing nociplastic pain in individuals with rheumatic diseases: a narrative review","volume":"75","author":"Murphy","year":"2023","journal-title":"Arthritis Care Res"},{"issue":"3","key":"2026050703121185200_zxaf326-B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain\u2013United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"issue":"11","key":"2026050703121185200_zxaf326-B105","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1136\/ard-2023-225327","article-title":"From fibrositis to fibromyalgia to nociplastic pain: how rheumatology helped get us here and where do we go from here?","volume":"83","author":"Clauw","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"2026050703121185200_zxaf326-B106","doi-asserted-by":"publisher","first-page":"CD010567","DOI":"10.1002\/14651858.CD010567.pub2","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia\u2014an overview of Cochrane reviews","volume":"2013","author":"Wiffen","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"2026050703121185200_zxaf326-B107","doi-asserted-by":"publisher","first-page":"563","DOI":"10.7326\/0003-4819-153-9-201011020-00005","article-title":"The epidemiology of pain during the last 2 years of life","volume":"153","author":"Smith","year":"2010","journal-title":"Ann Intern Med"},{"issue":"11","key":"2026050703121185200_zxaf326-B108","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1007\/s00520-017-3791-8","article-title":"A multicenter study of attitudinal barriers to cancer pain management","volume":"25","author":"Gunnarsdottir","year":"2017","journal-title":"Support Care Cancer"},{"issue":"1","key":"2026050703121185200_zxaf326-B109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.colegn.2021.02.008","article-title":"Barriers to adequate pain and symptom relief at the end of life: a qualitative study capturing nurses\u2019 perspectives","volume":"29","author":"Gerber","year":"2022","journal-title":"Collegian"},{"issue":"19","key":"2026050703121185200_zxaf326-B110","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1001\/jama.284.19.2495","article-title":"American College of Physicians\u2013American Society of Internal Medicine End-of-Life Care Consensus Panel. Seven legal barriers to end-of-life care: myths, realities, and grains of truth","volume":"284","author":"Meisel","year":"2000","journal-title":"JAMA"},{"issue":"1","key":"2026050703121185200_zxaf326-B111","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12910-021-00709-0","article-title":"Goods, causes and intentions: problems with applying the doctrine of double effect to palliative sedation","volume":"22","author":"Faris","year":"2021","journal-title":"BMC Med Ethics"},{"key":"2026050703121185200_zxaf326-B112","author":"Justia Law"},{"issue":"4","key":"2026050703121185200_zxaf326-B113","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/s0885-3924(01)00258-5","article-title":"Effects of high dose opioids and sedatives on survival in terminally ill cancer patients","volume":"21","author":"Morita","year":"2001","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"2026050703121185200_zxaf326-B114","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/pme.12464","article-title":"Alternative routes to oral opioid administration in palliative care: a review and clinical summary","volume":"15","author":"Kestenbaum","year":"2014","journal-title":"Pain Med"},{"issue":"2","key":"2026050703121185200_zxaf326-B115","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1089\/jpm.2006.0150","article-title":"Rational use of sublingual opioids in palliative medicine","volume":"10","author":"Reisfield","year":"2007","journal-title":"J Palliat Med"},{"issue":"5","key":"2026050703121185200_zxaf326-B116","doi-asserted-by":"publisher","first-page":"e632","DOI":"10.1016\/j.jpainsymman.2025.02.312","article-title":"From top to bottom: using oral formulation methadone rectally for pain","volume":"69","author":"Kanwar","year":"2025","journal-title":"J Pain Symptom Manage"},{"key":"2026050703121185200_zxaf326-B117","author":"Palliative Care Network of Wisconsin"},{"issue":"3","key":"2026050703121185200_zxaf326-B118","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1089\/jpm.2010.0302","article-title":"Assessing pain in nonresponsive hospice patients: development and preliminary testing of the Multidimensional Objective Pain Assessment Tool (MOPAT)","volume":"14","author":"McGuire","year":"2011","journal-title":"J Palliat Med"},{"issue":"1","key":"2026050703121185200_zxaf326-B119","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4037\/ajcc2010624","article-title":"Reliability and validity of the Face, Legs, Activity, Cry, Consolability behavioral tool in assessing acute pain in critically ill patients","volume":"19","author":"Voepel-Lewis","year":"2010","journal-title":"Am J Crit Care"},{"key":"2026050703121185200_zxaf326-B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinme.2025.100510","article-title":"How to distinguish opioid toxicity from natural dying in patients with advanced illness and how to manage opioid toxicity","volume":"5","author":"Boland","year":"2025","journal-title":"Clin Med"},{"issue":"6","key":"2026050703121185200_zxaf326-B121","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1177\/1049909114533002","article-title":"Palliative sedation: an analysis of international guidelines and position statements","volume":"32","author":"Gurschick","year":"2015","journal-title":"Am J Hosp Palliat Care"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxaf326\/65812823\/zxaf326.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/10\/470\/65812823\/zxaf326.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/10\/470\/65812823\/zxaf326.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T07:12:50Z","timestamp":1778137970000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/83\/10\/470\/8374508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":121,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,12,9]]},"published-print":{"date-parts":[[2026,5,7]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxaf326","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,15]]},"published":{"date-parts":[[2025,12,9]]}}}